Proudfoot et al., J. Biol. Chem., 1996, vol. 271, pp. 2599-2603.* |
Kruse et al., EMBO J., 1993, vol. 12, pp. 5121-5129.* |
Achen et al., “Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2(Flk1) and VEGF receptor 3(Flt4)” Proc. Natl. Aca. Sci. 95:548-553 (1998). |
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database programs”, Nucleic Acids Res. 25:3389-3402 (1997). |
Ausubel et al., “Current Protocols in Molecular Biology” eds. (1987). |
Beach and Nurse, “High-frequency transformation of the fission yeast Schizosaccharomyces pombe” Nature 290:140 (1981). |
C. Anthony, “The Biochemistry of Methylotrophs” Department of Biochemistry University of Southampton, England 269 (1982). |
Cohen et al. “High Levels of Biologically Active Vascular Endothelial Growth Factor (VEGF) are Produced by the Baculovirus Expression System”, Growth Factors 7:131-138 (1993). |
Cohen et al. “VEGF121, a Vascular Endothelial Growth Factor (VEGF) Isoform Lacking Heparin Binding Ability, Requires Cell-surface Heparan Sulfates for Efficient Binding to VEGF Receptors of Human Melanoma Cells”, J. Biol. Chem. 270:11322-11326 [1995]. |
Conn et al., “Purification of glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line”PNAS USA 87:1323-1327 (1990). |
Connolly et al., “Human Vascular Permeability Factor” J. Biol Chem. 264:20017-20024 [1989]. |
Connolly et al., “Tumot Vascular Permeability Factor Stimualtes Endothelial Cell Growth and Angiogenesis” J. Clin. Invest. 84: 1470-1478 (1989). |
Cregg et al. in, “High-Level Expression and Efficient Assembly of Hepatitis B Surface Antigen in: The Methylotrophic Yeast, Pichia Pastoris, Bio/Technology” 5:479-485 (1987). |
D. Gospodarowicz et al., “Isolation and Characterization of a Vascular Endothelial Cell Mitogen Produced by Pituitary-Derived Folliculo Stellate Cells” PNAS USA 86:7311-7215 (1989). |
Dvorak et al. “Distribution of Vascular Permeability Factor (Vascular Endothelial Growth Factor) in Tumors: Concentration in Tumor Blood Vessels” J. Exp. Med. 174:1275-1278 (1991). |
Ferrara and Henzel, “Pituitary Follicular Cells Secrete a Novel Heparin-Binding Growth Factor Specific for Vascular Endothelial Cells” Biochem. Biophys. Res. Comm. 161:851-858 (1988). |
Fiebich et al., :Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells Eur. J. Biochem 211:19-26 (1993). |
Fiers et al., “Complete nucleotide sequence of SV40 DNA” Nature 273:113 [1978]. |
Freshney, “Animal Cell Culture” ed. IRL Press (1987). |
Gait, “Oligonucleotide Synthesis” ed. IRL Press (1984). |
Gitay-Goren et al. “Selective Binding of VEGF121 to One the Three Vascualr Endothelial Growth Factor Receptors of Vascular Endothelial Cells”, J. Biol. Chem. 271:5519-5523 [1996]). |
Goeddel et al., “Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone” Nature 281:544 [1979]. |
Goto et al., “Synergistic Effects of Vascular Endothelial Growth Factor and Basic Fibroblast Growth factor on the Proliferation and Cord Formation of Bovine Capillary Enndothelial Cells Within Collagen Gels” Lab. Invest. 69:508-517 (1993). |
Graham et al, “Characteristics of Human Cell Line Transformed by DNA from Human Adenovirus Type 5” J. Gen. Virol. 36:59 [1977]. |
Hinnen, et al., “Transformation of Yeast” Proc. Natl. Acad, Sci. USA 75:1929-1933 [1978]. |
Hitzeman, et al., “Isolation and Characterization of the Yeast 3-Phosphoglycerokinase Gene (PGK) by an Immunological Screening Technique” J. Biol. Chem. 255:2073 [1980]. |
Holland et al., “Isolation and Identification of Yeast Messenger Ribonucleic Acids Coding for Enolase, Glucerldehyde-3-phosphate Dehydrogenase and Phosphoglycerate Kinase” Biochemistry 17:4900 (1978). |
Houck et al., “Dual Regulation of Vascualr Endothelial Growth Factor Bioavailability by Genentic and Proteolytic Mechanisms” J. Biol. Chem. 267:26031-26037 [1992]. |
Houck et al., “The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Altyernative Splicing of RNA” Mol. Endo. 5:1806-1814 [1991]. |
Keck et al., “Disulfide Structure of the Heparin Binding Domain in Vascular Endothelial Growth Factor: Caharacterization of Posttranswlational Modifications” Arch Biochem. Biophys. 344:103-113 (1997). |
Keck et al., “Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGH” Science 246:1309-1312 (1989). |
Kelly and Hynes, “Trasformation of Aspergillus niger by the amdS gene of Aspergillus nidularis” EMBO J. 4:475-479 [1985]. |
Kendall and Thomas, “Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor” PNAS USA 90:10705-10709 (1993). |
Keyt et al., “The Carboxyl-terminal Domain (111-165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency” J. Biol. Chem. 271:7788-7795 [1996]. |
Kim et al., “Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo” Nature 362:841-844 (1993). |
Kondo et al., “The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogeness and vascualr premeabiliyt” Biochim. Biophys. Acta 1243:195-202 [1995]. |
Koolwijk et al., “Cooperative Effect of TNFα, Bfgf, and vegf on the Formation of Tubular Sturctures of Human Microvascular Endothelial Cells in a Fibrin Matrix. Rile of Urokinase Activity” J. Cell Biol. 132: 1177-1188 (1996). |
Korz et al. “Simple fed-batch technique for high cell density cultivation of Escherichia coli”, J. Bacteriol. 39:59-65, (1995). |
Leung et al., “Vascular Endothelial Growth Factor Is A Secreted Angiogenic Mitogen” Science 246:1306-1309 (1989). |
Miller & Calos, “Gene Transfer Vectors for Mammalian Cells” ed. Current Communications in Molecular Biology (1987). |
Mohanraj et al., “A Novel Method to Purify Recombinant Vascular Endothelial Grwoth Factor (VEGF121) Expressed in Yeast” Biochem. Biophys. Res. Comm. 215:750-756 [1995]. |
Muller, et al., “Vascular endothelial growth factor:Crystal structure and functional mapping of the kinase domain receptor binding site” PNAS USA 94:7192-7197 [1997]. |
Mullis et al., “PCR: The Polymerase Chain Reaction” ed. Birkhauser (1994). |
Pepper et al., “Potent Synergism Between Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in the Induction of Angiogenesis In Vitro” Biochem. Biophys. Res. Commun. 189:824-831 (1992). |
Phillips et al., “Vascular Endothelial Growth Factor (rhVEGF165) Stimulates Direct Angiogenesis in the Rabbit Cornea” In Vivo 8:961-965 (1995). |
Plate et al., “Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo” Nature 359:845-848 (1992). |
Plouët et al., “Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells” EMBO. J. 8: 3801-3806 (1989). |
Sambrook et al., “Molecular Cloning:A Laboratory Manual”, Second Edition, Sections 1.82, 16.32-16.37 1988. |
Siemeister et al. “The α-Helical Domain Near the Amino Terminus is Essential for Dimerization of Vascular Endothelial Growth Factor” J. Biol. Chem. 273:11115-11120 [1998]. |
Siemeister et al., “Expression of Biologically Active Isoforms of the Tumor Angiogenesis Factor VEGF in Escherichia coli”, Biochem, Biophys. Res. Comm. 222:249-255 (1996). |
Soker et al., “Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor” Cell 92;735-745 [1998]. |
Soker et al., “Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF 165 via Its Exon 7-encoded Domain” J. Biol.Chem. 271:5761-5767 (1996). |
Tisher et al., “The Human Gene for Vascular Endothelial Growth Factor” J. Biol. Chem. 266:11947-11954 (1991). |
Urlaub and Chasin, “Isolation of Chinese Hamster Cell Mutants Deficient in Dihydrofolate Reductase Activity” Proc. Natl. Acad. Sci. USA 77:4216 [1980]. |
Vincenti et al., “Assignment of the Vascular Endothelial Growth Factor Genes to Human Chromosome 6p21.3” Circulation 93:1493-1495 (1996). |
Wagner and Hynes, “Domain Structure of Fibronectin and Its Relation to Function” J. Biol. Chem. 254:6746-6754 [1979]. |
Waltenberger et al., “Different Signal Transduction Properties of KDR and Flt1, Two Receptors for Vascualr Endothelial Growth Factor” J. Biol. Chem. 269:26988-26995 (1994). |
Wang and Hanson “Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers”, Journal of Parenteral Science and Technology, Technical Report No. 10, Supp. 42-2S (1988). |
Yang et al., “Substantially Attenuated Hemodynamic Responses to Escherichia coli-Derived Vascular Endothelial Growth Factor Given by Intravenous Infusion Compared with Bolus Injection” J. Pharmacol. Experimental Therpeutics 284: 103-110 (1998). |
Proudfoot et al., J. Biol. Chem., 1996, vol. 271, pp. 2599-2603.* |
Kruse et al., EMBO J., 1993, vol. 12, pp. 5121-5129. |